Private area
Contact Us
Total Visits
| Views | |
|---|---|
| Molecular ... | 77 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Molecular ... | 1 | 7 | 8 | 4 | 4 | 15 | 0 |
File Visits
| Views | |
|---|---|
| molecular-determinants-response-neoadjuvant-pembrolizumab-plus-chemotherapy-patients-high-risk-early-stage-triple-negative-breast-cancer-exploratory-analysis-open-label-2025.pdf | 25 |
Top country views
| Views | |
|---|---|
| United States | 29 |
| China | 9 |
| Singapore | 9 |
| Spain | 5 |
| Brazil | 4 |
| Hong Kong | 3 |
| Ireland | 3 |
| Mexico | 3 |
| Australia | 2 |
| Canada | 2 |
Top cities views
| Views | |
|---|---|
| Beijing | 8 |
| Singapore | 8 |
| Buffalo | 5 |
| Almont | 4 |
| Ashburn | 3 |
| Barcelona | 3 |
| Dublin | 3 |
| Hong Kong | 3 |
| Los Angeles | 3 |
| Mexico City | 3 |
